Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$3,172,847
+$48,660 QoQ
Shares Held
12,493
-2.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#1,966
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SCHMIDT P J INVESTMENT MANAGEMENT INC holds $37,992,630 across 7 Drug Manufacturers - General names. JNJ ranks #3 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
18,753 | $22,492,912 | |
| 2 | ABBV |
AbbVie Inc.
|
33,957 | $8,544,939 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
12,493 | $3,172,847 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,392 | $2,234,872 | |
| 5 | AMGN |
Amgen Inc
|
2,704 | $979,172 | |
| 6 | NVS |
Novartis AG
|
2,300 | $360,456 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,600 | $207,432 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,172,847 | 12,493 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,124,187 | 12,781 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $2,649,580 | 12,803 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $2,404,711 | 12,969 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $2,391,912 | 15,659 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $2,636,026 | 15,895 | Shares | Sole | 2025-05-21 | |
| 2024-12-31 | $2,333,009 | 16,132 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $2,688,413 | 16,589 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $2,602,671 | 17,807 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $2,880,956 | 18,212 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $3,201,257 | 20,424 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $4,038,597 | 25,930 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $4,336,292 | 26,198 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $4,187,015 | 27,013 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $5,429,691 | 30,737 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $5,283,552 | 32,343 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $7,326,192 | 41,272 | Shares | Sole | 2022-08-24 | |
| 2022-03-31 | $7,718,012 | 43,548 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $7,729,797 | 45,185 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $7,476,319 | 46,293 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $7,976,381 | 48,418 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $7,747,130 | 47,138 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $7,346,970 | 46,683 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $6,778,208 | 45,528 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $6,197,985 | 44,073 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $5,880,787 | 44,847 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||